Company Search:
Advanced Search
Sponsored Links
GW Pharmaceuticals PLC - ADR Company Snapshot
GW Pharmaceuticals PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other companies in this sector in the United States: Bioanalytical Systems, Inc. (2018 sales of $26.35 million ), argenx SE ($25.31 million of which 53% was Milestone Payments), and Verastem Inc ($26.72 million of which 100% was Pharmaceuticals preparation).

Sales Analysis. Sales increased substantially in 2018: GW Pharmaceuticals PLC reported sales of $26.62 million for the year ending December of 2018. This represents an increase of 153.4% versus 2017, when the company's sales were $10.50 million.
  Stock Performance Chart for GW Pharmaceuticals PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 109.41
(Figures in U.S. Dollars)
1 Week -19.7%   13 Weeks -4.4%  
4 Weeks -34.5%   52 Weeks -20.6%  
GW Pharmaceuticals PLC - ADR Key Data:
  Ticker: GWPH Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 26,616,101
(Year Ending Jan 2019).
Employees: 791
  Currency: U.S. Dollars Market Cap: 3,379,207,355
  Fiscal Yr Ends: December Shares Outstanding: 30,885,727
  Share Type: Common Closely Held Shares: 840,671
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.